Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
David Leverenz, MD Profile picture
David Leverenz, MD
@DavidLeverenz
Rheumatology fellowship PD at #DukeRheum. Alum of @VUMCMedicineRes. Crazy about #rheumatology. Creator of #RheumMadness. Views mine.
Apr 6, 2021 • 8 tweets • 5 min read
Time for a massive #RheumMadness thank you thread. This was a HUGE endeavor with so many contributors!

First, massive thanks to ALL OF YOU for participating! This project was always about inspiring collaborative learning. Thanks for playing, learning, debating, and sharing! Second, huge thanks to the @RheumResearch Foundation for supporting this project through the Clinician Scholar Educator award. All aspiring educators in rheumatology, consider applying for this award! It connects you with an amazing community of educators.
Mar 28, 2021 • 9 tweets • 2 min read
How well did the #RheumRibbonPanel match #RheumMadness participants' predictions in the #SeronegativeSixteen?

Belimumab for LN vs. Anifrolumab

👩‍⚖️Panel:
Belimumab for LN: 5
Anifrolumab: 2

👩‍💻Participants:
80% picked belimumab for LN

More in 🧵 below 👇 (1/8) PEXIVAS vs. Avacopan

👩‍⚖️Panel:
PEXIVAS: 3
Avacopan: 4

👩‍💻Participants:
66% picked avacopan

(2/8)